October 17th, 2013
Questioning Digoxin Use for Patients with Systolic HF
James Freeman, MD, MPH, MS
James Freeman discusses his research group’s evaluation of the contemporary effectiveness and safety of digoxin therapy among adults with newly diagnosed systolic heart failure.
October 22nd, 2012
Selections from Richard Lehman’s Literature Review: October 22nd
Richard Lehman, BM, BCh, MRCGP
This week’s topics include favorable lipid-level trends in U.S. adults, an angiotensin receptor neprilysin inhibitor for patients with HF and preserved systolic ejection fraction, and a long-term safety comparison of the Zotarolimus-eluting and Sirolimus-eluting coronary stents.
NEJM Journal Watch — Recent Cardiology Articles- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension
- Preventive PCI of Vulnerable Plaques Linked to Fewer Cardiac Events
- News from the ACC Scientific Sessions 2024